Company closes Series A and launches Tapestri™ to accelerate the discovery, development and delivery of precision medicine. ORLANDO, Fla. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mission Bio, ...

Tapestri introduced an app in November that pays consumers cash for sharing their anonymized location history. The startup then sells the data to brands. Tapestri founder and chief executive officer ...

New Tapestri® v3 brings a higher number of cells captured and greater standardization and robustness to single-cell DNA and multi-omics workflows to empower customer success SOUTH SAN FRANCISCO, Calif ...

Flagship App Pays Users for Location Data; Unique Compensation Model Drives Global Expansion CHICAGO, April 14, 2022 /PRNewswire/ -- Tapestri Inc., the app that pays users for sharing their anonymous ...

Mission Bio’s Tapestri® Platform and custom assay development platform supported exploratory biomarker analysis for Incyte’s INCA033989 clinical trial for myeloproliferative neoplasms (MPNs), enabling ...

Tapestri from Mission Bio is a precision genomics platform to support the discovery, development and delivery of precision medicine. The Tapestri platform leverages proprietary droplet microfluidics ...

Mission Bio has completed a $30 million Series B financing, saying it plans to use the proceeds toward expanding and further developing its single-cell DNA genomics platform Tapestri® for oncology; ...

CHICAGO, Nov. 30, 2021 /PRNewswire/ -- Tapestri Inc. today announced the launch of its namesake mobile application that pays users for sharing their anonymous location data and intends to expand to ...

SOUTH SAN FRANCISCO, Calif., Sept. 15, 2022 /PRNewswire/ -- Mission Bio, Inc., the pioneer in high-throughput single-cell DNA analysis, today announced new data supporting the use of its Tapestri ® ...

SOUTH SAN FRANCISCO, Calif., March 29, 2022 /PRNewswire/ -- Mission Bio, Inc., the pioneer in high-throughput single-cell DNA and multi-omics analysis, today launched the Tapestri Solution for Solid ...

Mission Bio’s Tapestri Single Cell Multi-Omics Platform for Exploratory Biomarker Analysis Supports Myeloproliferative Neoplasms (MPNs) Data Presentation at ASH 2025 Mission Bio’s Tapestri® Platform ...

The new Tapestri® v3 chemistry increases the number of cells captured per sample by up to four times compared to the prior chemistry, a notable enhancement. With enhanced cell capture, the Tapestri® ...